First report of safety and efficacy of a glycoPEGylated FVIII (N8-GP) in previously treated pediatric patients with severe hemophilia A-results from the international phase 3 pathfinder (TM) 5 trial
Makaleler > Özet · 2016
Yazarlar: Jayanthi ALAMELU, Silke EHRENFORTH, Hideji HANABUSA, Faraizah Abdul KARIM, Ramazan Kaan KAVAKLI, Melanie KHODAIE, Janice Stabar, Oleksandra STASYSHYN, Donald YEE, Lina RAGELIENE
HAEMOPHILIA, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2016, cilt 22, ss 49-50